Press Releases



All Releases
View Summary Sangamo BioSciences Announces Pricing Of Public Offering Of Common Stock
Mar 20, 2014
PDF 44.2 KB Add to Briefcase
View Summary Sangamo BioSciences Announces Public Offering Of Common Stock
Mar 19, 2014
PDF 43.4 KB Add to Briefcase
View Summary Sangamo Presents Clinical Data At CROI 2014 Demonstrating Enhancement Of SB-728-T Engraftment - Continued Control Of HIV Viral Load For 31 Weeks Without ART In SB-728-T Treated Subject
Mar 6, 2014
PDF 100.0 KB Add to Briefcase
View Summary First-In-Man Study Of Genome Editing Using Sangamo's ZFN Technology Published In New England Journal Of Medicine
Mar 5, 2014
PDF 47.7 KB Add to Briefcase
View Summary Sangamo BioSciences Announces Presentation At The 2014 Cowen And Company Health Care Conference
Feb 26, 2014
PDF 41.6 KB Add to Briefcase
View Summary Sangamo BioSciences Reports Fourth Quarter And Full Year 2013 Financial Results
Feb 11, 2014
PDF 22.7 KB Add to Briefcase
View Summary Sangamo BioSciences Announces Presentation At The 2014 Leerink Swann Global Healthcare Conference
Feb 6, 2014
PDF 8.4 KB Add to Briefcase
View Summary Sangamo BioSciences Announces Fourth Quarter And Full Year 2013 Conference Call And Webcast
Feb 4, 2014
PDF 8.7 KB Add to Briefcase
View Summary Sangamo BioSciences Announces Conference Call And Webcast To Discuss Global Collaboration with Biogen Idec to Develop Treatments for Hemoglobinopathies
Jan 9, 2014
PDF 8.3 KB Add to Briefcase
View Summary Biogen Idec and Sangamo BioSciences Announce Global Collaboration to Develop Treatments for Hemoglobinopathies
Jan 9, 2014
PDF 18.9 KB Add to Briefcase
View Summary Sangamo BioSciences to Focus on Advancing ZFP Therapeutic Pipeline at J.P. Morgan Healthcare Conference
Jan 8, 2014
PDF 11.0 KB Add to Briefcase
View Summary Sangamo BioSciences Presents Data From Non-Human Primates Providing Proof Of Concept For Disruptive And Broadly Leverageable Platform For Protein Replacement Therapies
Dec 10, 2013
PDF 13.4 KB Add to Briefcase
View Summary Sangamo BioSciences Announces First Presentation Of Data From ZFP Therapeutic Program For Treatment Of Sickle Cell Disease And Beta-Thalassemia At American Society Of Hematology Meeting
Dec 9, 2013
PDF 17.2 KB Add to Briefcase
View Summary Sangamo BioSciences Presents Clinical Data From Key SB-728-T HIV Studies: Proof Of Concept For Ongoing Sustained Functional Control Of HIV Viral Load; Cytoxan Preconditioning Successfully Enhances Engraftment
Dec 6, 2013
PDF 63.7 KB Add to Briefcase
View Summary Sangamo BioSciences Announces Presentation At The 25th Annual Piper Jaffray Healthcare Conference
Nov 25, 2013
PDF 8.3 KB Add to Briefcase
View Summary Sangamo BioSciences Announces Seven Data Presentations At The 2013 American Society of Hematology Annual Meeting
Nov 20, 2013
PDF 11.9 KB Add to Briefcase
View Summary Sangamo BioSciences Announces Presentation Of Clinical Data From Alzheimer's Disease Program
Nov 15, 2013
PDF 16.3 KB Add to Briefcase
View Summary Sangamo BioSciences Announces Presentation Of First Demonstration Of In Vivo Efficacy Of Novel ZFP Therapeutic® For Huntington's Disease
Nov 12, 2013
PDF 13.2 KB Add to Briefcase
View Summary Sangamo BioSciences Presents Clinical Data From SB-728-T HIV Study Demonstrating Long-Term Immune Reconstitution and Reduction in the HIV DNA Reservoir In Subjects with Long-Term Infection
Nov 4, 2013
PDF 14.5 KB Add to Briefcase
View Summary Sangamo BioSciences Presents Clinical Data From HIV Study Demonstrating Sustained Control Of Viremia
Oct 28, 2013
PDF 17.8 KB Add to Briefcase
Showing 1-20 of 471 Page: 1 2 3 4 5 ... 24  Next 20
Add to Briefcase = add release to Briefcase

Stock Quote

Ticker:
SGMO
Exchange:
NASDAQ
Price:
14.19
Change:
+ 0.17
Day High:
14.39
Day Low:
13.38
Volume:
1,057,900
4:00 PM ET on Apr 24, 2014

Shareholder Tools